Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN1202 in Bone Metastases
NCT01015560Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of plozalizumab in bone metastases, sponsored by SWOG Cancer Research Network. Started Mar 2010; status: completed.
02
Drugs
plozalizumab
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT01015560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015560.